This inventor holds 1 USPTO granted patent and 1 published patent application and 2 EPO patents. Top assignees: Centre Hospitalier Regional Et Universitaire De Lille (Chru), Université De Lille 2 Droit Et Santé, Universite Du Littoral Cote D'opale. Active years: 2018.
Company Filing History:
1 out of 10 
1 out of 13 
1 out of 3 Years Active: 2018
Title: Caroline Moreau: Innovator in Pharmaceutical Solutions for Parkinson's Disease
Introduction
Caroline Moreau is a notable inventor based in Lille, France. She has made significant contributions to the field of pharmaceuticals, particularly in the treatment of Parkinson's disease. Her innovative approach focuses on the formulation of a pharmaceutical solution that utilizes dopamine.
Latest Patents
Caroline holds 1 patent for her invention titled "Pharmaceutical solution comprising dopamine for use in treating Parkinson's disease." This invention is directed towards a pharmaceutical solution that comprises at least dopamine, specifically designed for treating Parkinson's disease. The unique aspect of her formulation is that it is maintained under anaerobic conditions from its formulation to its administration, ensuring the stability and efficacy of the solution.
Career Highlights
Throughout her career, Caroline has worked with esteemed institutions such as the Centre Hospitalier Régional et Universitaire de Lille and the Université du Littoral Côte d'Opale. Her work in these organizations has allowed her to advance her research and contribute to the medical community.
Collaborations
Caroline has collaborated with notable colleagues, including David Devos and Charlotte Laloux. These partnerships have enriched her research and have been instrumental in the development of her innovative solutions.
Conclusion
Caroline Moreau's contributions to the field of pharmaceuticals, particularly in the treatment of Parkinson's disease, highlight her role as an innovator. Her dedication to improving patient outcomes through her inventions is commendable.